JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB91025

Native Human IgA protein

Be the first to review this product! Submit a review

|

(7 Publications)

Native Human IgA protein is a Full Length protein with >95% purity and suitable for SDS-PAGE. The predicted molecular weight of ab91025 native protein is 160 kDa.

- Save time and ensure accurate results- use our native IgA protein as an isotype control
- No cross-reaction from other immunoglobulin isotypes

View Alternative Names

IGHA2, IGHA1, IGHA, Ig alpha 1 chain C region, Ig alpha 2 chain C region

1 Images
SDS-PAGE - Native Human IgA protein (AB91025)
  • SDS-PAGE

Unknown

SDS-PAGE - Native Human IgA protein (AB91025)

SDS-PAGE : 4-12% Bis-Tris NuPAGE gel
Lane 1 : 5 μg IgA (reduced/heated)
Lane 2 : 10 μg IgA (reduced/heated)
Lane 3 : 20 μg IgA (reduced/heated)
Lane 4 : Molecular weight markers
Lane 5 : 5 μg IgA (non-reduced/no heat)
Lane 6 : 10 μg IgA (non-reduced/no heat)
Lane 7 : 20 μg IgA (non-reduced/no heat)

Key facts

Purity

>95% SDS-PAGE

Expression system

Native

Tags

Tag free

Applications

SDS-PAGE

applications

Biologically active

No

Animal free

No

Carrier free

No

Storage buffer

pH: 8 Preservative: 0.05% Sodium azide Constituents: 1.58% Tris HCl, 0.58% Sodium chloride

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

The Native Human IgA protein ab91025 is prepared from plasma shown to be non reactive for HBsAg, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests.

Ensure the validity of your result using our native human Immunoglobulin A (IgA) protein as a control in SDS-PAGE.

Check out our protein gel staining guide for SDS-PAGE here.

Protein Determination: Extinction Coefficient (ε) 0.1% at 280 nm, 1 cm pathway = 1.32

Sequence info

[{"sequence":"","proteinLength":"Full Length","predictedMolecularWeight":"160 kDa","actualMolecularWeight":null,"aminoAcidEnd":0,"aminoAcidStart":0,"nature":"Native","expressionSystem":null,"accessionNumber":null,"tags":[]}]

Properties and storage information

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Immunoglobulin A (IgA) also known as sIgA in its secretory form is an important component of the immune system. With a molecular weight of approximately 160 kDa IgA exists as a monomeric or dimeric structure. It is primarily expressed in mucosal areas such as the respiratory tract gastrointestinal tract and urogenital tract while also being present in secretions like saliva tears and breast milk. In its dimeric form IgA associates with a joining (J) chain and a secretory component which facilitates its transport across mucosal barriers.
Biological function summary

IgA functions as a first line of defense in immune responses occurring at mucosal surfaces. Its primary role is to neutralize pathogens toxins and prevent their attachment and penetration through epithelial cells. This antibody does not form part of a larger complex but plays an important role in immune exclusion by trapping antigens in the mucus layer. Additionally IgA can mediate antibody-dependent cellular cytotoxicity and engage with specific receptors like FcαRI (CD89) on immune cells further enhancing its protective capabilities.

Pathways

IgA participates in the mucosal immune response which is a sub-component of the broader immune system pathways. It is closely associated with the polymeric immunoglobulin receptor (pIgR) which transports IgA to the mucosal surfaces. The pathway involves recombination activation proteins (RAG) during its class-switching process in B cells differentiating from IgM-producing cells to those secreting IgA. These pathways are integral to maintaining the mucosal environment and protecting against pathogens.

Alterations or deficiencies in IgA can lead to increased susceptibility to infections and disorders like IgA nephropathy and celiac disease. In IgA nephropathy IgA deposits in the kidneys result in inflammation and damage to renal tissues. Celiac disease involves an immune reaction to gluten where IgA antibodies against tissue transglutaminase (tTG) contribute to intestinal damage. Both conditions illustrate the importance of IgA in maintaining immune balance and its connection with disease pathologies.

Specifications

Form

Liquid

General info

Product protocols

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Pharmacological research 199:107048 PubMed38145833

2023

Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia.

Applications

Unspecified application

Species

Unspecified reactive species

Trang T Vu,Kyeongmin Kim,Millennium Manna,Justin Thomas,Bryan C Remaily,Emma J Montgomery,Travis Costa,Lauren Granchie,Zhiliang Xie,Yizhen Guo,Min Chen,Alyssa Marie M Castillo,Samuel K Kulp,Xiaokui Mo,Sridhar Nimmagadda,Paul Gregorevic,Dwight H Owen,Latha P Ganesan,Thomas A Mace,Christopher C Coss,Mitch A Phelps

Immunity 56:2570-2583.e6 PubMed37909039

2023

Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers.

Applications

Unspecified application

Species

Unspecified reactive species

Subir Biswas,Gunjan Mandal,Carmen M Anadon,Ricardo A Chaurio,Luis U Lopez-Bailon,Mate Z Nagy,Jessica A Mine,Kay Hänggi,Kimberly B Sprenger,Patrick Innamarato,Carly M Harro,John J Powers,Joseph Johnson,Bin Fang,Mostafa Eysha,Xiaolin Nan,Roger Li,Bradford A Perez,Tyler J Curiel,Xiaoqing Yu,Paulo C Rodriguez,Jose R Conejo-Garcia

Frontiers in medicine 10:1267670 PubMed37869168

2023

Differential levels of anti--specific IgAs in saliva of household contacts with latent tuberculosis infection.

Applications

Unspecified application

Species

Unspecified reactive species

Cinthya Ruiz-Tagle,Rodrigo Naves,Patricia García,Anna Günther,Nicole Schneiderhan-Marra,María Elvira Balcells

Scientific reports 13:17820 PubMed37857783

2023

Utility of nasal swabs for assessing mucosal immune responses towards SARS-CoV-2.

Applications

Unspecified application

Species

Unspecified reactive species

Ericka Kirkpatrick Roubidoux,Pamela H Brigleb,Kasi Vegesana,Aisha Souquette,Kendall Whitt,Pamela Freiden,Amanda Green,Paul G Thomas,Maureen A McGargill,Joshua Wolf,Stacey Schultz-Cherry

Proteomics 23:e2200321 PubMed36625099

2023

Identification of salivary autoantibodies as biomarkers of oral cancer with immunoglobulin A enrichment combined with affinity mass spectrometry.

Applications

Unspecified application

Species

Unspecified reactive species

Hao-Wei Chu,Kai-Ping Chang,Wei-Chen Yen,Hao-Ping Liu,Xiu-Ya Chan,Chiao-Rou Liu,Chu-Mi Hung,Chih-Ching Wu

Journal of human lactation : official journal of International Lactation Consultant Association 37:492-498 PubMed34297643

2021

SARS-CoV-2 Antibodies Detected in Mother's Milk Post-Vaccination.

Applications

Unspecified application

Species

Unspecified reactive species

Jill K Baird,Shawn M Jensen,Walter J Urba,Bernard A Fox,Jason R Baird

Nature 591:464-470 PubMed33536615

2021

IgA transcytosis and antigen recognition govern ovarian cancer immunity.

Applications

Unspecified application

Species

Unspecified reactive species

Subir Biswas,Gunjan Mandal,Kyle K Payne,Carmen M Anadon,Chandler D Gatenbee,Ricardo A Chaurio,Tara Lee Costich,Carlos Moran,Carly M Harro,Kristen E Rigolizzo,Jessica A Mine,Jimena Trillo-Tinoco,Naoko Sasamoto,Kathryn L Terry,Douglas Marchion,Andrea Buras,Robert M Wenham,Xiaoqing Yu,Mary K Townsend,Shelley S Tworoger,Paulo C Rodriguez,Alexander R Anderson,Jose R Conejo-Garcia
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com